Kathryn Rudie Harrigan
Plus aucun poste en cours
Profil
Kathryn Rudie Harrigan served as an Independent Director at Cambrex Corp.
from 1994 to 2019.
She was also a Member of the Governors Board at Ronin Development Corp.
Additionally, she worked as a Professor at Columbia Business School.
Prior to her career, she earned an undergraduate degree from Macalester College, an MBA from The University of Texas at Austin, and a doctorate from Harvard University.
Anciens postes connus de Kathryn Rudie Harrigan
| Sociétés | Poste | Fin |
|---|---|---|
| CAMBREX CORPORATION | Directeur/Membre du Conseil | 04/12/2019 |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
| Ronin Development Corp. | Directeur/Membre du Conseil | - |
| Columbia Business School | Corporate Officer/Principal | - |
Formation de Kathryn Rudie Harrigan
| Macalester College | Undergraduate Degree |
| The University of Texas at Austin | Masters Business Admin |
| Harvard University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
| Ronin Development Corp. |
